Back to results
US 2020/0046673 A1Published application
Method of treating patients with a factor Xa inhibitor, Aspirin, and Verapamil
AssigneeMorgandane Scientific, LLC
InventorsChristina CHOW, Sundar SRINIVASAN
Life of this patent
Estimating the term…
Abstract
The present disclosure in various embodiments teaches methods of treating patients in need of treatment with a Factor Xa inhibitor, and who are also concomitantly administered aspirin and verapamil.
Claims25
A method of treating a patient in need of treatment with rivaroxaban, comprising:
- (a) administering about 100 to about 480 mg of verapamil daily to the patient;
- (b) administering about 75 mg to about 325 mg of aspirin to the patient;
- and
- (c) administering about 0.5 mg to less than about 2.5 mg of rivaroxaban to the patient.
1 more element
(canceled)
-15. (canceled)
-19. (canceled)
-24. (canceled)
-50. (canceled)
Dependencies are inferred from the claim text.